The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
Open accessAbstract
Lipid nanoparticles (LNP) are effective delivery vehicles for messenger RNA (mRNA) and have shown promise for vaccine applications. Yet there are no published reports detailing how LNP biophysical properties can impact vaccine performance. In our hands, a retrospective analysis of mRNA LNP vaccine in vivo studies revealed a relationship between LNP particle size and immunogenicity in mice using LNPs of various compositions. To further investigate this, we designed a series of studies to systematically change LNP particle size without altering lipid composition and evaluated biophysical properties and immunogenicity of the resulting LNPs. While small diameter LNPs were substantially less immunogenic in mice, all particle sizes tested yielded a robust immune response in non-human primates (NHP).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global trends in emerging infectious diseases
Jones, K. E., Patel, N. G., Levy, M. A., Storeygard, A., Balk, D., Gittleman, J. L., & Daszak, P. (2008) · Nature · doi:10.1038/nature06536 · Cited by 8,338
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,406
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness
Corbett, K. S., Edwards, D. K., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., et al. (2020) · Nature · doi:10.1038/s41586-020-2622-0 · Cited by 1,615
Self-citationNanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)
Lefkowitz, E. J., Dempsey, D. M., Hendrickson, R. C., Orton, R. J., Siddell, S. G., & Smith, D. B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx932 · Cited by 1,227
Marsh, M., & Helenius, A. (2006) · Cell · doi:10.1016/j.cell.2006.02.007 · Cited by 1,186
SARS-CoV-2 (COVID-19) by the numbers
Bar-On, Y. M., Flamholz, A., Phillips, R., & Milo, R. (2020) · eLife · doi:10.7554/elife.57309 · Cited by 962
Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines
Hassett, K. J., Benenato, K. E., Jacquinet, E., Lee, A., Woods, A., Yuzhakov, O., Himansu, S., Deterling, J., Geilich, B. M., Ketova, T., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.013 · Cited by 927
Self-citationZhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Sabnis, S., Kumarasinghe, E. S., Salerno, T., Mihai, C., Ketova, T., Senn, J. J., Lynn, A., Bulychev, A., McFadyen, I., Chan, J., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.010 · Cited by 820
Self-citationTools for translation: non-viral materials for therapeutic mRNA delivery
Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799
Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 796
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642
Self-citationNiikura, K., Matsunaga, T., Suzuki, T., Kobayashi, S., Yamaguchi, H., Orba, Y., Kawaguchi, A., Hasegawa, H., Kajino, K., Ninomiya, T., et al. (2013) · ACS Nano · doi:10.1021/nn3057005 · Cited by 638
Developing mRNA-vaccine technologies
Schlake, T., Thess, A., Fotin-Mleczek, M., & Kallen, K.-J. (2012) · RNA Biology · doi:10.4161/rna.22269 · Cited by 622
Patel, S., Ashwanikumar, N., Robinson, E., Xia, Y., Mihai, C., Griffith, J. P., Hou, S., Esposito, A. A., Ketova, T., Welsher, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14527-2 · Cited by 601
Yanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., Dabkowska, A., Székely, N., Radulescu, A., Bergenholtz, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720542115 · Cited by 534
Assembly of endocytic machinery around individual influenza viruses during viral entry
Rust, M. J., Lakadamyali, M., Zhang, F., & Zhuang, X. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb769 · Cited by 474
Material design for lymph node drug delivery
Schudel, A., Francis, D. M., & Thomas, S. N. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0110-7 · Cited by 460
Microfluidic Directed Formation of Liposomes of Controlled Size
Jahn, A., Vreeland, W. N., DeVoe, D. L., Locascio, L. E., & Gaitan, M. (2007) · Langmuir · doi:10.1021/la070051a · Cited by 429
Liang, F., Lindgren, G., Lin, A., Thompson, E. A., Ols, S., Röhss, J., John, S., Hassett, K., Yuzhakov, O., Bahl, K., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.006 · Cited by 395
Self-citationVaccines for the twenty-first century society
Rappuoli, R., Mandl, C. W., Black, S., & De Gregorio, E. (2011) · Nature Reviews Immunology · doi:10.1038/nri3085 · Cited by 388
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.
Oussoren, C., Zuidema, J., Crommelin, D. J. A., & Storm, G. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00122-3 · Cited by 380
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Sung, M. M. H., Tam, Y. K., & Cullis, P. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.059 · Cited by 366
Human Immunodeficiency Virus (HIV)
German Advisory Committee Blood (Arbeitskreis Blut), S. ‘. O. P. T. B. B. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000445852 · Cited by 355
Impact of mRNA chemistry and manufacturing process on innate immune activation
Nelson, J., Sorensen, E. W., Mintri, S., Rabideau, A. E., Zheng, W., Besin, G., Khatwani, N., Su, S. V., Miracco, E. J., Issa, W. J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6893 · Cited by 354
Understanding modern-day vaccines: what you need to know
Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1407035 · Cited by 354
Cureton, D. K., Massol, R. H., Saffarian, S., Kirchhausen, T. L., & Whelan, S. P. J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000394 · Cited by 348
Liposomes to target the lymphatics by subcutaneous administration
Oussoren, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00154-5 · Cited by 342
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
Hewitt, S. L., Bai, A., Bailey, D., Ichikawa, K., Zielinski, J., Karp, R., Apte, A., Arnold, K., Zacharek, S. J., Iliou, M. S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9143 · Cited by 316
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
Kanchan, V., & Panda, A. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.015 · Cited by 283
Size-dependent cellular uptake and localization profiles of silver nanoparticles
Wu, M., Guo, H., Liu, L., Liu, Y., & Xie, L. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s201107 · Cited by 282
Pollard, C., Rejman, J., De Haes, W., Verrier, B., Van Gulck, E., Naessens, T., De Smedt, S., Bogaert, P., Grooten, J., Vanham, G., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.202 · Cited by 248
John, S., Yuzhakov, O., Woods, A., Deterling, J., Hassett, K., Shaw, C. A., & Ciaramella, G. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.029 · Cited by 229
Self-citationKimura, N., Maeki, M., Sato, Y., Note, Y., Ishida, A., Tani, H., Harashima, H., & Tokeshi, M. (2018) · ACS Omega · doi:10.1021/acsomega.8b00341 · Cited by 227
Kose, N., Fox, J. M., Sapparapu, G., Bombardi, R., Tennekoon, R. N., de Silva, A. D., Elbashir, S. M., Theisen, M. A., Humphris-Narayanan, E., Ciaramella, G., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw6647 · Cited by 202
Overviews of Pathogen Emergence: Which Pathogens Emerge, When and Why?
Cleaveland, S., Haydon, D. T., & Taylor, L. H. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-70962-6_5 · Cited by 195
Espeseth, A. S., Cejas, P. J., Citron, M. P., Wang, D., DiStefano, D. J., Callahan, C., Donnell, G. O., Galli, J. D., Swoyer, R., Touch, S., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0163-z · Cited by 190
Li, X., Aldayel, A. M., & Cui, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.032 · Cited by 190
Phagocytosis Dynamics Depends on Target Shape
Paul, D., Achouri, S., Yoon, Y.-Z., Herre, J., Bryant, C. E., & Cicuta, P. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.07.036 · Cited by 185
Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread
McCloskey, B., Dar, O., Zumla, A., & Heymann, D. L. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70846-1 · Cited by 165
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Leung, A. K. K., Tam, Y. K., & Cullis, P. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.025 · Cited by 160
Modulating the immune system through nanotechnology
Dacoba, T. G., Ana, O., Torres, D., Crecente‐Campo, J., & Alonso, M. J. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.007 · Cited by 160
Ott, G., Barchfeld, G. L., & Nest, G. V. (1995) · Vaccine · doi:10.1016/0264-410x(95)00089-j · Cited by 147
Katare, Y. K., Muthukumaran, T., & Panda, A. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.028 · Cited by 143
Howard, G. P., Verma, G., Ke, X., Thayer, W. M., Hamerly, T., Baxter, V. K., Lee, J. E., Dinglasan, R. R., & Mao, H. (2019) · Nano Research · doi:10.1007/s12274-019-2301-3 · Cited by 133
A strategy for synthesis of lipid nanoparticles using microfluidic devices with a mixer structure
Maeki, M., Saito, T., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2015) · RSC Advances · doi:10.1039/c5ra04690d · Cited by 123
De Beuckelaer, A., Pollard, C., Van Lint, S., Roose, K., Van Hoecke, L., Naessens, T., Udhayakumar, V. K., Smet, M., Sanders, N., Lienenklaus, S., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.161 · Cited by 122
The Impact of Size on Particulate Vaccine Adjuvants
Shah, R. R., O’Hagan, D. T., Amiji, M. M., & Brito, L. A. (2014) · Nanomedicine · doi:10.2217/nnm.14.193 · Cited by 117
Self-citationRoles of Sterol Derivatives in Regulating the Properties of Phospholipid Bilayer Systems
Bui, T. T., Suga, K., & Umakoshi, H. (2016) · Langmuir · doi:10.1021/acs.langmuir.5b04343 · Cited by 89
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia
An, D., Frassetto, A., Jacquinet, E., Eybye, M., Milano, J., DeAntonis, C., Nguyen, V., Laureano, R., Milton, J., Sabnis, S., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.003 · Cited by 87
Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines
Carstens, M. G., Camps, M. G. M., Henriksen‐Lacey, M., Franken, K. L. M. C., Ottenhoff, T. H. M., Perrie, Y., Bouwstra, J. A., OSSENDORP, F. A., & Jiskoot, W. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.081 · Cited by 73
Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery
He, Z., Hu, Y., Nie, T., Tang, H., Zhu, J., Chen, K., Liu, L., Leong, K. W., Chen, Y., & Mao, H. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.047 · Cited by 73
Yan, S., Gu, W., & Xu, Z. P. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.11.061 · Cited by 51
Emerging Challenges and Opportunities in Infectious Disease Epidemiology
Lewnard, J. A., & Reingold, A. L. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy264 · Cited by 50
Cited by
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Hald Albertsen, C., Kulkarni, J. A., Witzigmann, D., Lind, M., Petersson, K., & Simonsen, J. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114416 · Cited by 1,185
Chemistry of Lipid Nanoparticles for RNA Delivery
Eygeris, Y., Gupta, M., Kim, J., & Sahay, G. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00544 · Cited by 873
Lee, Y., Jeong, M., Park, J., Jung, H., & Lee, H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01086-x · Cited by 450
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery
Maeki, M., Uno, S., Niwa, A., Okada, Y., & Tokeshi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.017 · Cited by 349
Muramatsu, H., Lam, K., Bajusz, C., Laczkó, D., Karikó, K., Schreiner, P., Martin, A., Lutwyche, P., Heyes, J., & Pardi, N. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.001 · Cited by 331
Metadata
- Authors
- Hassett, K. J., Higgins, J., Woods, A., Levy, B., Xia, Y., Hsiao, C. J., Acosta, E., Almarsson, Ö., Moore, M. J., & Brito, L. A.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 335
- Pages
- 237-246
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3160196662
- Cited by
- 367
- References
- 68
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.